Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Sodhi, G.S., et al., 2023
In the EMPA-REG study, empagliflozin significantly reduced the risk for the composite renal outcome, which included doubling of serum creatinine, progression of macroalbuminuria, initiation of renal replacement therapy, or renal death (56)
muciniphila phylogroups encoded glycoside hydrolases (GHs) and glycosyltransferases (GTs), but the copy numbers of the GH and GT families differed from one another (Becken et al., 2021
Xu M, Cai J, Wei H, Zhou M, Xu P, Huang H, et al
US$ 29.56
US$ 23.62
US$ 23.39
US$ 22.14
